Unsolicited Bid Causes Applied Imaging to Raise Price Genetix Must Pay for It | GenomeWeb
NEW YORK (GenomeWeb News) — Applied Imaging today said that an unsolicited bid from a third party to acquire all of its outstanding shares has caused it to the raise by around 24 percent the original price that suitor Genetix will pay to acquire it.
 
Genetix will now pay around $22.7 million for Applied Imaging after the companies amended the terms of the acquisition on Nov. 2 following the unsolicited bid.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.